Second Line Capital’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$409K Buy
1,103
+107
+11% +$31.9K 0.08% 100
2025
Q4
$329K Buy
996
+2
+0.2% +$678 0.07% 104
2025
Q3
$343K Sell
994
-5,275
-84% -$1.6M 0.07% 97
2025
Q2
$1.96M Sell
6,269
-133
-2% -$50.8K 0.45% 43
2025
Q1
$3.35M Buy
6,402
+553
+9% +$283K 0.86% 29
2024
Q4
$2.96M Buy
5,849
+812
+16% +$461K 0.8% 30
2024
Q3
$2.94M Buy
5,037
+239
+5% +$135K 0.8% 25
2024
Q2
$2.44M Buy
4,798
+402
+9% +$197K 0.75% 30
2024
Q1
$2.17M Buy
4,396
+373
+9% +$190K 0.71% 36
2023
Q4
$2.12M Buy
+4,023
New +$2.15M 0.85% 27

Other funds holding UNH

Second Line Capital's UNH Position: Q1 2026 in Review

Second Line Capital increased its UnitedHealth (UNH) stake by 11% in Q1 2026, buying an estimated $31.9K and bringing the position to 1,103 shares worth $409K. The position accounts for 0.08% of the portfolio, ranked #100.

Second Line Capital first reported a position in UNH in Q4 2023 and has held it in 10 quarters since. The position peaked at $3.35M in Q1 2025. 3,026 funds tracked by Wall St. Rank hold UNH as of Q1 2026.

  • Second Line Capital held 1,103 shares of UnitedHealth worth $409K as of Q1 2026.
  • Second Line Capital bought 107 UnitedHealth shares in Q1 2026, an estimated $31.9K.
  • UnitedHealth made up 0.08% of Second Line Capital's portfolio in Q1 2026, its #100 holding.
  • Second Line Capital first reported a position in UnitedHealth in Q4 2023 and has held it in 10 quarters since.
  • Second Line Capital's UnitedHealth position peaked at $3.35M in Q1 2025.
  • 3,026 funds tracked by Wall St. Rank held UnitedHealth as of Q1 2026.

Based on Second Line Capital's 13F filing for Q1 2026, filed 15 May 2026.